Adherence to lipid lowering drugs is associated with ldl-cholesterol goal achievement.

被引：0
作者：
Pladevall, M. [1 ]
Williams, K. L. [1 ]
Lafata, J. Elston [1 ]
Tunceli, K. [1 ]
Wang, M. [1 ]
Campbell, I. [1 ]
Divine, G. [1 ]
Yang, J. [1 ]
机构：
[1] Henry Ford Hlth Syst, Detroit, MI USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2007年 / 165卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [21] The final word about LDL-cholesterol lowering
    Streja, Dan
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2018, 25 (02) : 101 - 102
  • [22] Time to LDL-cholesterol goal attainment in Spain
    Olivares, Q
    Mabe, I
    Nocea, G
    Alemao, E
    Caloto, T
    Fosbrook, L
    Ahumada, C
    Yin, D
    VALUE IN HEALTH, 2004, 7 (06) : 685 - 685
  • [23] Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
    Khan, Safi U.
    Michos, Erin D.
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 1
  • [24] LDL-cholesterol goal attainment according to cardiovascular risk level in patients receiving lipid-lowering therapy in primary care
    Laforest, L.
    Souchet, T.
    Ritleng, C.
    Desamericq, G.
    Kieffer, A.
    Le Jeunne, P.
    Van Ganse, E.
    EUROPEAN HEART JOURNAL, 2007, 28 : 601 - 601
  • [25] Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada
    Gitt, Anselm K.
    Drexel, Heinz
    Feely, John
    Ferrieres, Jean
    Gonzalez-Juanatey, Jose R.
    Thomsen, Kristian K.
    Leiter, Lawrence A.
    Lundman, Pia
    da Silva, Pedro M.
    Pedersen, Terje
    Wood, David
    Juenger, Claus
    Dellea, Pam S.
    Sazonov, Vasilisa
    Chazelle, Francois
    Kastelein, John J. P.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (02) : 221 - 230
  • [26] Lowering of LDL-cholesterol may increase risk of cancer
    Reactions Weekly, 2007, 1164 (1) : 2 - 2
  • [27] Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital
    Sangsawang, Tamon
    Sriwijitkamol, Apiradee
    VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 : 563 - 567
  • [28] Intensive LDL-cholesterol lowering therapy and neurocognitive function
    Banach, Maciej
    Rizzo, Manfredi
    Nikolic, Dragana
    Howard, George
    Howard, VirginiaJ.
    Mikhailidis, DimitriP.
    PHARMACOLOGY & THERAPEUTICS, 2017, 170 : 181 - 191
  • [29] Predictors of LDL-cholesterol goal achievement in secondary prevention in Europe and Canada: results of the Dyslipidemia International Study
    Gitt, A. K.
    Juenger, C.
    Smolka, W.
    Bestehorn, K.
    Lundman, P.
    Leiter, L.
    Pedersen, T.
    Gonzalez-Juanatey, J.
    Chazelle, F.
    Kastelein, J.
    EUROPEAN HEART JOURNAL, 2010, 31 : 373 - 373
  • [30] Molecular pathways and agents for lowering LDL-cholesterol in addition to statins
    Costet, Philippe
    PHARMACOLOGY & THERAPEUTICS, 2010, 126 (03) : 263 - 278
12345